APON(SZ:300753) Ge Long Hui·2025-09-22 07:17Core Viewpoint - The company has launched its new generation ADM series anesthesia depth monitoring products, although the revenue scale is currently small [1] Product Development - The multimodal ADHD behavioral training system has recently obtained two medical device registration certificates and production licenses, but has not yet generated revenue [1] - The external layout of Changzhou Ruishen'an has recently received registration certificates for implanted deep brain stimulators (CNS) and implanted drug delivery devices (IDDS) [1] Strategic Partnerships - The company has signed a partnership with the Children's Hospital affiliated with Fudan University to establish a joint laboratory [1] - The company has strategically invested in a specialized service organization focused on ADHD behavioral training therapy, known as Fangcun Doctor, to conduct in-depth cooperation [1] Research and Development Focus - The company will continue to advance clinical applications in perioperative brain state monitoring, diagnosis of sleep disorders, ADHD, epilepsy, and other mental health conditions [1] - The establishment of an Artificial Intelligence and Brain-Machine Engineering Research Institute aims to explore more possibilities at the intersection of brain-machine interface technology and clinical applications, driven by cutting-edge technology [1]